Nephrotoxicity Induced by Cisplatin Intake in Experimental Rats and Therapeutic Approach of Using Mesenchymal Stem Cells and Spironolactone

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Applied Biochemistry and Biotechnology

• Publication date

  2018-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s12010-017-2631-0PMID 29043663
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The basics of epithelial–mesenchymal transition (EMT): A study from a structure, dynamics, and functional perspective

  2019cited by this paper
• The Inhibitory Effect of Mesenchymal Stem Cells with rAd-NK4 on Liver Cancer

  2017cited by this paper
• Preconditioning with melatonin improves therapeutic outcomes of bone marrow-derived mesenchymal stem cells in targeting liver fibrosis induced by CCl4

  2017cited by this paper
• Proteomic Analysis Reveals the Contribution of TGFβ/Smad4 Signaling Pathway to Cell Differentiation During Planarian Tail Regeneration

  2017cited by this paper
• Renal protective effects of arjunolic acid in a cisplatin-induced nephrotoxicity model.

  2016cited by this paper
• Effect of Vanadyl Rosiglitazone, a New Insulin-Mimetic Vanadium Complexes, on Glucose Homeostasis of Diabetic Mice

  2016cited by this paper
• Obesity and Clinical Riskiness Relationship: Therapeutic Management by Dietary Antioxidant Supplementation—a Review

  2015cited by this paper
• Cuscuta chinensis Ameliorates Immunosuppression and Urotoxic Effect of Cyclophosphamide by Regulating Cytokines - GM-CSF and TNF-Alpha

  2015influential reference
• Mild ischemic Injury Leads to Long-Term Alterations in the Kidney: Amelioration by Spironolactone Administration

  2015cited by this paper
• Hepatocyte growth factor regulates the TGF-β1-induced proliferation, differentiation and secretory function of cardiac fibroblasts

  2014cited by this paper
• Hematopoietic stem cells derived from human umbilical cord ameliorate cisplatin-induced acute renal failure in rats.

  2014cited by this paper
• Novel targets of antifibrotic and anti-inflammatory treatment in CKD

  2014cited by this paper
• Reduction of chronic rejection of renal allografts by anti-transforming growth factor-β antibody therapy in a rat model.

  2013cited by this paper
• 3',4'-Bis-difluoromethoxycinnamoylanthranilate (FT061): an orally-active antifibrotic agent that reduces albuminuria in a rat model of progressive diabetic nephropathy.

  2013cited by this paper
• Synergistic Growth-Suppressive Effects of Quercetin and Cisplatin on HepG2 Human Hepatocellular Carcinoma Cells

  2013cited by this paper
• Evaluation of renal protective effects of inhibiting TGF-β type I receptor in a cisplatin-induced nephrotoxicity model.

  2013cited by this paper
• Reduction of chronic rejection of renal allografts by anti-transforming growth factor beta antibody therapy

  2012cited by this paper
• The insulin-like growth factor system in chronic kidney disease: Pathophysiology and therapeutic opportunities

  2012cited by this paper
• Subcellular targets of cisplatin cytotoxicity: an integrated view.

  2012cited by this paper
• Identifying the Regulative Role of NF-κB Binding Sites Within Promoter Region of Human Matrix Metalloproteinase 9 (mmp-9) by TNF-α Induction

  2012influential reference
• An integrative view of the pathophysiological events leading to cisplatin nephrotoxicity

  2011cited by this paper
• Renal fibrosis: novel insights into mechanisms and therapeutic targets

  2010cited by this paper
• Human marrow-derived mesenchymal stromal cells decrease cisplatin renotoxicity in vitro and in vivo and enhance survival of mice post-intraperitoneal injection.

  2010cited by this paper
• Klotho and kidney disease.

  2010cited by this paper
• Anaphylatoxin C5a contributes to the pathogenesis of cisplatin-induced nephrotoxicity.

  2009cited by this paper
• Endovenous administration of bone-marrow-derived multipotent mesenchymal stromal cells prevents renal failure in diabetic mice.

  2009cited by this paper
• Molecular mechanisms regulating dissociation of cell–cell junction of epithelial cells by oxidative stress

  2009cited by this paper
• The basics of epithelial-mesenchymal transition.

  2009cited by this paper
• Lineage‐Negative Bone Marrow Cells Protect Against Chronic Renal Failure

  2009cited by this paper
• EMT and proteinuria as progression factors.

  2009cited by this paper
• The nuclear factor NF-kappaB pathway in inflammation.

  2009cited by this paper
• TGF-beta signal transduction in chronic kidney disease.

  2009cited by this paper
• Reversal of experimental renal fibrosis by BMP7 provides insights into novel therapeutic strategies for chronic kidney disease

  2008cited by this paper
• Mesenchymal stem cells in acute kidney injury.

  2008cited by this paper
• Systemic administration of multipotent mesenchymal stromal cells reverts hyperglycemia and prevents nephropathy in type 1 diabetic mice.

  2008cited by this paper
• Genistein protects the kidney from cisplatin-induced injury.

  2008cited by this paper
• Endotoxin and cisplatin synergistically stimulate TNF-α production by renal epithelial cells

  2007cited by this paper
• Therapeutic potential of bone marrow-derived mesenchymal stem cells on experimental liver fibrosis.

  2007cited by this paper
• Endotoxin and cisplatin synergistically stimulate TNF-alpha production by renal epithelial cells.

  2007influential reference
• Biochemical mechanisms of cisplatin cytotoxicity.

  2007cited by this paper
• Endotoxin and cisplatin synergistically induce renal dysfunction and cytokine production in mice.

  2007influential reference
• Insulin-like growth factor-1 sustains stem cell mediated renal repair.

  2007cited by this paper
• Treatment targets in renal fibrosis.

  2007cited by this paper
• Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition.

  2007cited by this paper
• Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice

  2006cited by this paper
• Renal fibrosis: new insights into the pathogenesis and therapeutics.

  2006cited by this paper
• Ischemic acute renal failure induces the expression of a wide range of nephrogenic proteins.

  2006cited by this paper
• [Hepatocyte growth factor and kidney].

  2006cited by this paper
• C5b-9 does not mediate chronic tubulointerstitial disease in the absence of proteinuria.

  2005cited by this paper
• Kidney tubular epithelium is restored without replacement with bone marrow-derived cells during repair after ischemic injury.

  2005cited by this paper
• C5b-9 regulates peritubular myofibroblast accumulation in experimental focal segmental glomerulosclerosis.

  2004cited by this paper
• Hepatocyte growth factor in kidney fibrosis: therapeutic potential and mechanisms of action.

  2004cited by this paper
• Prevention of progressive fibrosis in chronic renal diseases: antifibrotic agents.

  2004cited by this paper
• Mesenchymal stem cells: isolation and therapeutics.

  2004cited by this paper
• Diabetic kidney disease in the db/db mouse.

  2003cited by this paper
• Reversibility of established diabetic glomerulopathy by anti-TGF-beta antibodies in db/db mice.

  2003cited by this paper
• The inflammatory component in progressive renal disease--are interventions possible?

  2002cited by this paper
• Hepatocyte growth factor and the kidney

  2002cited by this paper
• Obstructive nephropathy and renal fibrosis.

  2002cited by this paper
• Hepatocyte growth factor: renotropic role and potential therapeutics for renal diseases.

  2001cited by this paper
• Connective tissue growth factor in tubulointerstitial injury of diabetic nephropathy.

  2001cited by this paper
• Basic fibroblast growth factor expression is increased in human renal fibrogenesis and may mediate autocrine fibroblast proliferation.

  2000cited by this paper
• Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice.

  2000cited by this paper
• Molecular basis of renal fibrosis

  2000cited by this paper
• Hepatocyte growth factor protects renal epithelial cells from apoptotic cell death.

  1998cited by this paper
• Potential role of hepatocyte growth factor in the maintenance of renal structure: anti-apoptotic action of HGF on epithelial cells.

  1998cited by this paper
• Mycophenolate mofetil attenuates renal injury in the rat remnant kidney.

  1998cited by this paper
• Human renal fibroblasts modulate proximal tubule cell growth and transport via the IGF-I axis.

  1997cited by this paper
• IGF-I induces collagen and IGFBP-5 mRNA in rat intestinal smooth muscle.

  1997cited by this paper
• Autocrine regulation of growth in cultured human intestinal muscle by growth factors.

  1997cited by this paper
• Renal fibrosis: insights into pathogenesis and treatment.

  1997cited by this paper
• Molecular insights into renal interstitial fibrosis.

  1996cited by this paper
• Insulin-like growth factor I induces mesangial proliferation and increases mRNA and secretion of collagen.

  1995cited by this paper
• Extracellular matrix contains insulin-like growth factor binding protein-5: potentiation of the effects of IGF-I

  1993cited by this paper
• Antifibrotic effects of spironolactone in preventing myocardial fibrosis in systemic arterial hypertension.

  1993cited by this paper
• Glomerular lesions in mice transgenic for growth hormone and insulinlike growth factor-I. I. Relationship between increased glomerular size and mesangial sclerosis.

  1990cited by this paper
• Histopathology associated with elevated levels of growth hormone and insulin-like growth factor I in transgenic mice.

  1989cited by this paper
• Growth enhancement of transgenic mice expressing human insulin-like growth factor I.

  1988cited by this paper
• Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction

  1979influential reference
• Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction.

  1979cited by this paper
• Improved method for the determination of blood glutathione.

  1963cited by this paper

• The Role of Mesenchymal Stem Cells in Treating Diabetic Kidney Disease: Immunomodulatory Effects and Kidney Regeneration

  2025cites this paper
• Combined effect of naringin and adipose tissue-derived mesenchymal stem cell on cisplatin nephrotoxicity through Sirtuin1/Nrf-2/HO-1 signaling pathway: a promising nephroprotective candidate

  2024cites this paper
• The Effects of Sunitinib in Healthy and Cisplatin‐Induced Rats

  2023cites this paper
• Therapeutic potential and protection enhancement of mesenchymal stem cell against cisplatin-induced nephrotoxicity using hyaluronic acid-chitosan nanoparticles as an adjuvant.

  2023cites this paper
• Enhancing the Therapeutic Potential of Mesenchymal Stromal Cell-Based Therapies with an Anti-Fibrotic Agent for the Treatment of Chronic Kidney Disease

  2022cites this paper
• Nuclear receptors in renal health and disease

  2022cites this paper
• Zinc oxide nanoparticles and spironolactone-enhanced Nrf2/HO-1 pathway and inhibited Wnt/β-catenin pathway in adenine-induced nephrotoxicity in rats

  2022cites this paper
• Impact of preconditioning stem cells with all-trans retinoic acid signaling pathway on cisplatin-induced nephrotoxicity by down-regulation of TGFβ1, IL-6, and caspase-3 and up-regulation of HIF1α and VEGF

  2021cites this paper
• Role of mineralocorticoid receptor antagonists in kidney diseases

  2020cites this paper
• Pre-treatment with Beta Carotene Gives Protection Against Nephrotoxicity Induced by Bromobenzene via Modulation of Antioxidant System, Pro-inflammatory Cytokines and Pro-apoptotic Factors

  2020cites this paper
• Adipose Tissue–Derived Mesenchymal Stem Cells Protect Against Amiodarone-Induced Lung Injury in Rats

  2020cites this paper
• SYNTHESIS, CHARACTERIZATION, DNA BINDING, AND ANTICANCER ABILITY OF A Co(II) COMPLEX CONSTRUCTED BY 2-PROPYL-1H-IMIDAZOLE-4,5-DICARBOXYLIC ACID

  2020cites this paper
• All-trans retinoic acid has renoprotective effects on Cisplatin-induced acute kidney injury in rats.

  2020cites this paper
• Synthesis, characterization, DNA binding and anticancer ability of a Yb (III) complex constructed by 1,4-bis(pyrazol-1-yl)terephthalic acid

  2019cites this paper
• Sirt5 Attenuates Cisplatin-Induced Acute Kidney Injury through Regulation of Nrf2/HO-1 and Bcl-2

  2019cites this paper
• Spironolactone but not Eplerenone Exacerbates Cisplatin Nephrotoxicity

  2019cites this paper
• Arsenic trioxide and curcumin attenuate cisplatin-induced renal fibrosis in rats through targeting Hedgehog signaling

  2019cites this paper
• Long Non-coding RNA Expression Profiling in Biopsy to Identify Renal Allograft at Risk of Chronic Damage and Future Graft Loss

  2019cites this paper
• Antifibrotic Roles of RAAS Blockers: Update

  2019cites this paper
• Mesenchymal Stem Cells: a Promising Therapeutic Tool for Acute Kidney Injury

  2019cites this paper
• Inflammation and renal fibrosis: Recent developments on key signaling molecules as potential therapeutic targets

  2018cites this paper